Drug Induced Movement Disorders

The second revised edition of this text will update and present current state of the art clinical approaches to this subject. This book will continue to be the source text of information on drug-induced movement disorders authored and edited by the pioneers in the field. It will be an invaluable addition to the library of any neurologist.

Contents

• Section 1: General Considerations
• Chapter 1: Movement Disorders: Approach, Definitions and differential Diagnosis
  Martin Cloutier, Anthony E. Lang
• Chapter 2: Rating Scales for Movement Disorders.
  Wonodi I, Hong EH, Avila MT, Gunvant Thaker
• Chapter 3: Spontaneous movement disorders in psychiatric patients
  Irene Richard, Christopher O’Brien, Roger Kurlan
• Section 2: Antipsychotics
• Chapter 4: Pharmacology of typical and atypical agents
  Gary Remington, Shitij Kapur
• Chapter 5: Acute Drug-induced Dystonia
  Michael F. Mazurek, Patricia I. Rosebush
• Chapter 6: Drug-Induced Parkinsonism
  Joseph H. Friedman, Martha E. Trieschmann, Hubert H. Fernandez
• Chapter 7: Acute Akathisia
  Author: Lenard A. Adler, John Rotrosen, Burt Angrist
• Chapter 8: Neuroleptic Malignant Syndrome
  Stewart A. Factor
• Chapter 9: Classical Tardive Dyskinesia
  Thomas M. Hyde, MD, Jose A. Apud, Whitney C. Fisher, Michael F. Egan.
• Chapter 10: Tardive dyskinesia Variants
  Skidmore F, Weiner W, Burke R.
• Chapter 11: Movement Disorders caused by atypical antipsychotics
  Karen E. Anderson
• Chapter 12: Commentary: Is Tardive dyskinesia disappearing?James Lohr, MD
• Section 3: Dopaminomimetic Drugs
• Chapter 13: Dyskinesia induced by levodopa and dopamine agonists in Parkinson’s disease.
  John G. Nutt, Matthew Brodsky
• Chapter 14: Stimulant Drugs
  Anthony E. Munson, Juan Sanchez-Ramos, William J Weiner
• Section 5: Other Drugs
• Chapter 15: Antidepressants
  Marie L. Moro-de-Casillas, David E. Riley
• Chapter 16: Anticonvulsants
  John C. Morgan, Madeline Harrison
• Chapter 17: Miscellaneous Drugs
  Daniel Tarsy